Cat.#: ACPP-1220
Despition | ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion |
SIZE | 250 µg |
Applications | Immunodepletion & Immunocompetition assay |
Storage | Store at -20⁰C for long term |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1131 | Recombinant Human/Murine/Rat BDNF Protein (AC1131) | 50 µg | inquiry |
ACPP-1782 | TPX E.coli (AC1782) | 5 µg | inquiry |
ACPP-1240 | PAX5 Blocking Peptide (AC1240) | 250 µg | inquiry |
ACPP-1760 | Human Thyroid Stimulating Hormone Receptor (Active) Protein (AC1760) | 100 µg | inquiry |
ACPP-1024 | Recombinant Human FGF2 Protein (mutated Q65I + C96S + N111G). (AC1024) | 50 µg | inquiry |
ACPP-1742 | Human PRND Protein (AC1742) | 2 µg | inquiry |
ACPP-1132 | Recombinant Human Calbindin Protein (AC1132) | 25 µl | inquiry |
ACPP-1296 | Human FGF 19 Protein (AC1296) | 5 µg | inquiry |
ACPP-1819 | Human TRH Protein (AC1819) | 100 mg | inquiry |
ACPP-1330 | PAX2 Blocking Peptide (AC1330) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.